Depressive symptoms in urticaria patients treated with first- or second-generation histamine 1 receptor antagonists.
Kalogeromitros
Dimitris
D
Papageorgiou
Charalabos
C
Gregoriou
Stamatis
S
Chatziantonakis
Nikolaos
N
Makris
Michael
M
Spanoudaki
Nectaria
N
Rabavilas
Andreas
A
Rigopoulos
Dimitris
D
Theoharides
Theoharis C
TC
D000328:Adult; D000368:Aged; D017332:Cetirizine / Q000009:adverse effects / Q000627:therapeutic use; D003866:Depressive Disorder / Q000139:chemically induced* / Q000523:psychology; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D039563:Histamine H1 Antagonists, Non-Sedating / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006919:Hydroxyzine / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D014581:Urticaria / Q000150:complications / Q000188:drug therapy / Q000523:psychology*
D006634:Histamine H1 Antagonists; D039563:Histamine H1 Antagonists, Non-Sedating; D006919:Hydroxyzine; D017332:Cetirizine